$CCRN

FITZGERALD GALE S sold (to issuer) $1.1M of CCRN (indirect holdings)

FITZGERALD GALE S sold (to issuer) 79,918 indirectly-held shares of CROSS COUNTRY HEALTHCARE INC (CCRN) at $13.25 ($1.06M total) on 2026-07-21.

Original reporting
SEC EDGAR · FITZGERALD GALE S
Published Jul 21, 2026, 8:10 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 21, 2026, 8:11 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$CCRN
Neutral
high confidence
Mentioned
$CCRN
Relevance
6/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$CCRNNeutralLow
01

Why it matters

The disclosure updates the insider’s position (ending at 0 shares) but does not introduce new company performance, guidance, or legal/regulatory developments.

02

Market read

Traders may note the director’s complete exit, but the filing lacks a fundamental catalyst.

03

What to watch

Indirect holdings and the absence of a 10b5-1 plan detail do not, by themselves, establish intent or future trading behavior.

Relevance 6/10Novelty 2/10Timing: Filed 2026-07-21, after-hours/late-day SEC Form 4 disclosure.

Background

This is an SEC Form 4 insider transaction for Cross Country Healthcare, reported as a sale to the issuer with indirect holdings.

Company-level read

Ticker impact

$CCRNNeutralHigh confidence
Context

Cross Country Healthcare director Fitzgerald sold 79,918 shares to the issuer at $13.25/share, leaving 0 shares after the transaction.

Expected impact

Likely limited near-term impact; any effect is more about signaling than fundamentals.

Evidence & confidence

Form 4 discloses the transaction size, price, and post-transaction holdings, but provides no new operating, financial, or regulatory information.

Market effects

No clear sector read-through from a single director sale tied to issuer repurchase mechanics.

None indicated.

None indicated.

Counterpoint

The sale is to the issuer (often buyback participation) and may be mechanical rather than a bearish signal.

Key entities

  • CROSS COUNTRY HEALTHCARE INC

    Subject of the Form 4 insider transaction; director sold shares to the issuer.

  • FITZGERALD GALE S

    Director who sold 79,918 shares at $13.25/share, indirect holdings, ending with 0 shares.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$LWAYLow

Divisadero Street Capital Management, LP (Zolezzi William) purchased $6.1M of LWAY (indirect holdings)

Divisadero Street Capital Management, LP purchased 246,568 indirectly-held shares of Lifeway Foods, Inc. (LWAY) at an average of $24.85 ($24.69–$24.87, $6.13M total) across 3 trades over 2026-08-13 to 2026-08-17. Filed jointly with Divisadero Street Partners GP, LLC (10% owner), Divisadero Street Capital, LLC (10% owner), Divisadero Street Partners, L.P. (10% owner) and Zolezzi William (10% owner).